Cipla Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open-

High-

Low-

Prev. Close-

Avg. Traded Price-

Volume-

MARKET DEPTH

Total bid0.00

Total ask0.00

Orders	Qty	Bid

Ask	Qty	Orders

HIGH/LOW

52w

LOW/HIGH

₹1,480.00a day ago

₹1,510.50a day ago

LOWER/UPPER CIRCUITS

₹1,352.60

₹1,653.00

Cipla Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 7.12%, in the last year to ₹28,409.49 Cr. Its sector's average revenue growth for the last fiscal year was 10.81%.

Annual Net Profit,rose 27.93% in the last year to ₹5,272.52 Cr. Its sector's average net profit growth for the last fiscal year was 38.61%.

Price to Earning Ratio,is 23.06, lower than its sector PE ratio of 41.74.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 23.13%

Net profit growth 5Y CAGR : 22.45%

STOCK RETURNS

Versus Nifty 50

1 w

+2.14%

+1.58%

1 mth

+0.67%

+0.87%

3 mth

+4.63%

+11.89%

6 mth

+5.28%

+2.41%

1 yr

-1.25%

+7.8%

3 yr

+57.40%

+55.18%

5 yr

+136.44%

+152.1%

Cipla Ltd Top mutual funds holding

Franklin India Opportunities Fund(G)

3Y Return+34.9%

NAV₹246.48

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

3Y Return+29.8%

NAV₹39.37

Similar stocks

SUNPHARMA₹1,687.80+0.40 (0.02%)

DIVISLAB₹6,667.00-58.00 (0.86%)

DRREDDY₹1,362.50-0.20 (0.01%)

TORNTPHARM₹3,252.50-6.30 (0.19%)

MANKIND₹2,381.30-8.70 (0.36%)

Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.

Grow your wealth with more research recommendations

+91

We're all set for a new experience. To visit the old Ventura website, click here.

Ventura Wealth Clients Login here